Seizure: European Journal of Epilepsy
Volume 19, Issue 7 , Pages 383-389 , September 2010

Senile myoclonic epilepsy: Delineation of a common condition associated with Alzheimer's disease in Down syndrome

  • Roberto De Simone

      Affiliations

    • Centre Saint Paul - Hôpital Henri Gastaut, 300 Boulevard Sainte Marguerite, 13258 Marseille 09, France
    • Unità di Neurologia – Centro di diagnosi e cura delle epilessie, Ospedale Sant’Eugenio, Piazzale Umanesimo 10, 00144 Roma, Italy
    • ,
  • Xavier Salas Puig

      Affiliations

    • Servicio de Neurologia Hospital General de Asturias, Oviedo, Spain
    • ,
  • Philippe Gélisse

      Affiliations

    • Epilepsy Unit, Hopital Gui de Chauliac, 34295 Montpellier Cedex, France
    • ,
  • Arielle Crespel

      Affiliations

    • Epilepsy Unit, Hopital Gui de Chauliac, 34295 Montpellier Cedex, France
    • ,
  • Pierre Genton

      Affiliations

    • Centre Saint Paul - Hôpital Henri Gastaut, 300 Boulevard Sainte Marguerite, 13258 Marseille 09, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 491 170 750; fax: +33 491 170 791.

Received 2 December 2009 ,Accepted 9 April 2010.

References 

  1. Veall RM. The prevalence of epilepsy among mongols related to age. J Ment Def Res. 1974;18:99–106
  2. Stafstrom CE, Gilmore HE, Ehrenberg GL. Seizures in persons with Down syndrome: cause and prognosis. Ann Neurol. 1988;24:308–309
  3. Stafstrom CE, Patxot OF, Gilmore HE, Wisniewski KE. Seizures in children with Down syndrome: etiology, characteristics and outcome. Dev Med Child Neurol. 1991;33:191–200
  4. Stafstrom CE. Epilepsy in Down syndrome: clinical aspects and possible mechanisms. Am J Ment Ret. 1993;98(Suppl.):12–26
  5. Pueschel SM, Louis S, Mc Knight P. Seizure disorders in Down syndrome. Arch Neurol. 1991;3(March (48)):318–320
  6. Bittles AH, Bower C, Hussain R, Glasson EJ. The four ages of Down syndrome. Eur J Public Health. 2007;17(April (2)):221–225
  7. Schweber MS. Alzheimer's disease and Down syndrome. Prog Clin Biol Res. 1989;317:247–267
  8. Margallo-Lana ML, Moore PB, Kay DW, Perry RH, Reid BE, Berney TP, et al. Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology. J Intellect Disabil Res. 2007;51(June (Pt. 6)):463–477
  9. Lai F, Williams RS. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol. 1989;46:849–853
  10. Evenhuis HM. The natural history of dementia in Down's syndrome. Arch Neurol. 1990;47:263–267
  11. Genton P, Paglia G. Epilepsie myoclonique sénile? Myoclonies d’apparition tardive dans le syndrome de Down. Epilepsies. 1994;1:5–11
  12. Li LM, O’Donoghue MF, Sander JW. Myoclonic epilepsy of late onset in trisomy 21. Arq. Neuropsiquiatr. 1995;53(December (4)):792–794[Review]
  13. Möller JC, Hamer HM, Oertel WH, Rosenow F. Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS). Seizure. 2001;10(June (4)):303–305
  14. Möller JC, Hamer HM, Oertel WH, Rosenow F. Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS). Seizure. 2002;11(April (Suppl. A)):303–305
  15. De Simone R, Daquin G, Genton P. Senile myoclonic epilepsy in Down syndrome: a video and EEG presentation of two cases. Epileptic Disord. 2006;8:223–227
  16. Crespel A, Gonzalez V, Coubes P, Gelisse P. Senile myoclonic epilepsy of Genton: two cases in Down syndrome with dementia and late-onset epilepsy. Epilepsy Res. 2007;77:165–168
  17. Pedersen B. Epilepsy of late onset in Down's syndrome: a new epileptic syndrome. Epilepsia. 1990;31(5):613
  18. Van Allen MI, Fung J, Jurenka SB. Heath care concerns and guidelines for adults with Down syndrome. Am J Med Genet. 1999;89(2):100–110
  19. Tatsuno M, Hayashi M, Iwamoto H, Suzuki Y, Kuroki Y. Epilepsy in childhood Down syndrome. Brain Dev. 1984;6(1):37–44
  20. Kwoiong KL, Wong V. Neurodevelopmental profile of Down syndrome in Chinese people. J Paediatr Child Health. 1996;32(2):153–157
  21. McVicker RW, Shanks OEP, McClelland RJ. Prevalence and associated features of epilepsy in adults with Down's syndrome. B J Psychiatry. 1994;164:528–532
  22. Guerrini R, Genton P, Bureau M, Dravet C, Roger J. Reflex seizures are frequent in patient with Down syndrome and epilepsy. Epilepsia. 1990;31:406–417
  23. Pueschel SM, Louis S. Reflex seizures in Down syndrome. Child's Nerv Syst. 1993;9(February (1)):23–24
  24. Guerrini R, Battaglia A, Stagi P, Bureau M, Genton P, Camara-Silva A, et al. Caratteristiche elettrocliniche dell’epilessia nella sindrome di Down. Boll Lega It Epil. 1989;66/67:317–319
  25. Kemper TL. Neuropathology of Down syndrome. In:  Nadel L editors. The psychopathology of Down syndrome. Cambridge, MA: MIT Press; 1988;p. 269–289
  26. Wisniewski KE, Laure-Kamionowska M, Connell F, Wen GY. Neuronal density and synaptogenesis in the postnatal stage of brain maturation in Down syndrome. In:  Epstein C editors. The neurobiology of Down syndrome. New York, NY: Raven Press; 1986;p. 29–44
  27. Scott BS, Petit TL, Becker LE, Edwards BAV. Abnormal electric membrane properties of Down's syndrome DRG neurons in cell culture. Brain Res. 1982;2:257–270
  28. McCoy EE, Enns L. Current status of neurotransmitters abnormalities in Down syndrome. In:  Epstein CJ editors. The neurobiology of Down syndrome. 1986;p. 73–87
  29. Florez J, del Arco C, Gozales A, Pascual J, Pazos A. Autoradiographic studies of neurotransmitter receptors in the brain of newborn infants with Down syndrome. Am J Med Gen Sup. 1990;7:301–305
  30. Eubanks JH, Puranam RS, Kleckner NW, Bettler B, Heinemann SF, McNamara JO. The gene encoding the glutamate receptor subunit GluR5 is located on human chromosome 21q21.1–22.1 in the vicinity of the gene for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA. 1993;90:178–182
  31. Thiel RJ, Fowkes SW. Down syndrome and epilepsy: a nutritional connection?. Med Hypotheses. 2004;62:35–44
  32. Werbach M. Epilepsy. Textbook of nutritional medicine. Tarzana, CA: Third Line Press; 1999;p. 363–75
  33. Johannsen P, Christensen JEJ, Goldstein H, Nielsen VK, Mai J. Epilepsy in Down syndrome—prevalence in three age groups. Seizure. 1996;5(June (2)):121–125
  34. Hauser WA, Morris ML, Heston LL, Anderson VE. Seizures and myoclonus in patients with Alzheimer's disease. Neurology. 1986;36:1226–1230
  35. Wilkins DE, Hammett M, Berardelli A, Walshe T, Alvarez N. Physiological analysis of the myoclonus of Alzheimer's disease. Neurology. 1984;34:898–903
  36. Bugiani O, Tagliavini F, Giaccone G. Preamyloid deposits, amyloid deposits, and senile plaques in Alzheimer's disease, Down syndrome, and aging. Ann NY Acad Sci. 1991;640:122–128
  37. Wisniewsky H, Wiegel J, Popovitch E. Age associated development of diffuse and thioflavin 5-positive plaques in Down syndrome. Dev Br Dysf. 1995;7:330–339
  38. Prasher VP, Krishnan VHR. Age of onset and duration of dementia in people with Down syndrome. Integration of 98 reported cases in the literature. Int J Geriatr Psychiatry. 1993;10:25–31
  39. Rumple B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R, et al. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. NEJM. 1989;320:1446–1452
  40. Lockstone HE, Harris LW, Swatton JE, Wayland MT, Holland AJ, Bahn S. Gene expression profiling in the adult Down syndrome brain. Genomics. 2007;90(December (6)):647–660
  41. Lott IT, Head E, Doran E, Busciglio J. Beta-amyloid, oxidative stress and Down syndrome. Curr Alzheimer Res. 2006;3(December (5)):521–528
  42. Cheon MS, Dierssen M, Kim SH, Lubec G. Protein expression of BACE1, BACE2 and APP in Down syndrome brains. Amino Acids. 2007;[December 29; Epub ahead of print]
  43. Ryoo SR, Jeong HK, Radnaabazar C, Yoo JJ, Cho HJ, Lee HW, et al. DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease. J Biol Chem. 2007;282(November (48)):34850–34857
  44. Menéndez M. Down syndrome, Alzheimer's disease and seizures. Brain Dev. 2005;27(June (4)):246–252
  45. Prasher VP, Sajith SG, Rees SD, Patel A, Tewari S, Schupf N, et al. Significant effect of APOE epsilon 4 genotype on the risk of dementia in Alzheimer's disease and mortality in persons with Down syndrome. Int J Geriatr Psychiatry. 2008;[May 8; Epub ahead of print]
  46. Schupf N. Genetic and host factors for dementia in Down's syndrome. Br J Psychiatry. 2002;180:405–410
  47. Collacott RA, Cooper SA. Epilepsy in adults with Down syndrome. Br J Psychiatry. 1994;165(July (1)):117
  48. Aylward EH, Burt DB, Thorpe LU, Lai F, Dalton A. Diagnosis of dementia in individuals with intellectual disability. J Intell Disabil Res. 1997;41:152–164
  49. Thomas P, Genton P, Gelisse P, Wolf P. Epilepsie myoclonique juvénile. In: Les syndromes épileptiques de l’enfant et de l’adolescent. John Libbey Eurotext. p. 269–88.
  50. Dolk H, Loane M, Garne E, De Walle H, Queisser-Luft A, De Vigan C, et al. Trends and geographic inequalities in the prevalence of Down syndrome in Europe, 1980–1999. Rev Epidemiol Sante Publique. 2005;53(November (Spec No. 2)):2S87–95
  51. de Vigan C, Khoshnood B, Cadio E, Vodovar V, Goffinet F. Prenatal diagnosis and prevalence of Down syndrome in the Parisian population, 2001–2005. Gynecol Obstet Fertil. 2008;36(2):146–150

PII: S1059-1311(10)00083-X

doi: 10.1016/j.seizure.2010.04.008

Seizure: European Journal of Epilepsy
Volume 19, Issue 7 , Pages 383-389 , September 2010

Article Tools

* Image Usage & Resolution